It's not a political argument, the U.S. healthcare system is a mess. Costs are spiraling, more and more are uninsured, and the burden on the federal government over the coming years will be enormous. It appears to be all gloom and all bad. Of course, all these problems mean that there's some mad money to be made by any companies that can help sort out this mess. I'd like to think that is the thinking behind the wild opening day pop in shares of WebMD (NASD: WBMD) whose shares shot up nearly 40% on it's first day of trading. This is despite the fact that the company is a money losing operation, and has no prospects of turning a profit. Even the Motley Fool got this one right with their article WebMD Makes Me Sick. On second thought, if the Motley Fool hates it, perhaps it's worth taking a look. (In reality the IPO's jump is probably just a return to the days when IPOs just jumped a lot, and companies left a lot of money on the table...oh and investment bankers and their friends took all that money that was left on the table).
The other big healthcare news of the day was that General Electric (NYSE: GE) bought out healthcare IT concern IDX Corp. (NASD: IDXC) sending that company's shares up over 20%. You'll recall we spotlighted healthcare IT a few months ago suggesting it may be an intriguing space. At the time we made note of IMS health (NYSE: RX), which then became a buyout subject itself, as it waits to get swallowed by VNU. Here's what HIStalk (a fine blog on Healthcare IT) has to say about the IDX buyout:
The conference call just ended. IDX says that "some months ago" it
realized it couldn't scale to meet the available opportunities and
looked extensively for a partner. IDX states that the product lines of
the two companies fit "hand in glove." They think the UK relationship
will be enhanced because GE Healthcare is headquartered in the UK. They
will live up to the Allscripts agreement, which is a ten-year strategic
alliance in which IDX markets the Allscripts product and Allscripts
markets the IDX practice management product. GE will not be able to
sell their product in an IDX account for which IDX was obligated to
bring in Allscripts, so that's still an exclusive deal.
Synergies
seen: (1) revenue cycle for physician offices; (2) GE lacks a core CDR;
(3) workflow in radiology that links to GE PACS. They admit some
conflict with their ten-year agreement with Philips-Stentor and GE
PACS. The CDR (CareCast) application was barely mentioned.
At this point, The Stalwart isn't terribly optimistic that any of these moves will have much of a meaningful impact on the industry or costs. Despite the tremendous amount of R&D in the space, it's probably stuff like MinuteClinic which we discussed that could have the biggest impact on the industry, since much of the cost is due to regulation and poor institutional structures. Still, there's gotta be some huge profits somewhere that someone's not taking, it's just doubtful that WebMD, which was once thought to be a healthcare revolutionary, is gonna be it.